UDP glucuronosyltransferase 2 family, polypeptide B1, also known as UGT2B1, is an
enzyme that in humans is encoded by the UGT2B1gene.[5][6]
Function
The
olfactory neuroepithelium, which lines the posterior nasal cavity, is exposed to a wide range of
odorants and airborne toxic compounds. Odorants, which are mostly small
lipophilic molecules, enter the
mucus flow and reach the
odorant receptors on
sensory neurons. Odorant sensing is generally a transient process, requiring an effective signal termination, which could be provided by biotransformation of the odorant in the epithelial supporting cells.
Xenobiotic-metabolizing enzymes in the
olfactory epithelium have been suggested to catalyze inactivation and facilitate elimination of odorants.[6] UGT2A1 and
UGT2A2 were recently implicated as having a role in the loss of smell associated with
COVID-19.[7]
^Shelton, Janie F.; Shastri, Anjali J.; Aslibekyan, Stella; Auton, Adam; Auton, Adam (2021). "The UGT2A1/UGT2A2 locus is associated with COVID-19-related anosmia | medRxiv".
medRxiv10.1101/2021.05.28.21257993v1.
Tukey RH, Strassburg CP (2001). "Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract". Mol. Pharmacol. 59 (3): 405–14.
doi:
10.1124/mol.59.3.405.
PMID11179432.
S2CID21500183.
Ross CJ, Katzov-Eckert H, Dubé MP, et al. (2009). "Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy". Nat. Genet. 41 (12): 1345–9.
doi:
10.1038/ng.478.
PMID19898482.
S2CID21293339.
Mackenzie PI, Bock KW, Burchell B, et al. (2005). "Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily". Pharmacogenet. Genomics. 15 (10): 677–85.
doi:
10.1097/01.fpc.0000173483.13689.56.
PMID16141793.